EP 0049731 B1 19841205 - ANTHELMINTIC IMIDAZO(2,1-B)THIAZOLE GEL COMPOSITIONS
Title (en)
ANTHELMINTIC IMIDAZO(2,1-B)THIAZOLE GEL COMPOSITIONS
Publication
Application
Priority
US 19553280 A 19801009
Abstract (en)
[origin: US4287176A] The invention relates in general to aqueous, thermally revisible gels containing d1- or 1-6-phenyl-2,3,5,6-tetrahydro (-) imidazo[2,1-b]thiazole, acylamino derivatives thereof and pharmaceutically acceptable salts thereof, characterized by sub-zero gelation temperatures, storage stability and satisfactory anthelmintic activity. The invention relates in particular to gels containing levamisole, tetramisole, butamisole or benzamisole. The invention further relates to methods of use of the gels for the control of helminths infecting homothermic farm and companion animals.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/107 (2006.01); A61K 31/425 (2006.01); A61K 47/00 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/24 (2006.01); A61K 47/32 (2006.01); A61P 33/00 (2006.01); A61P 33/10 (2006.01)
CPC (source: EP US)
A61K 9/0056 (2013.01 - EP US); A61K 31/425 (2013.01 - EP US); A61P 33/00 (2017.12 - EP); A61P 33/10 (2017.12 - EP)
Designated contracting state (EPC)
BE CH DE FR GB IT LI LU NL SE
DOCDB simple family (publication)
US 4287176 A 19810901; AU 548957 B2 19860109; AU 7063481 A 19820422; CA 1166570 A 19840501; DE 3167565 D1 19850117; DK 166993 B1 19930816; DK 210181 A 19820410; EP 0049731 A2 19820421; EP 0049731 A3 19820922; EP 0049731 B1 19841205; ES 502519 A0 19820401; ES 8203221 A1 19820401; HK 81789 A 19891020; JP H0136443 B2 19890731; JP S5767514 A 19820424; NZ 197070 A 19830902; PT 73109 A 19810701; PT 73109 B 19820906; ZA 813235 B 19820630
DOCDB simple family (application)
US 19553280 A 19801009; AU 7063481 A 19810515; CA 378979 A 19810603; DE 3167565 T 19810509; DK 210181 A 19810512; EP 81103563 A 19810509; ES 502519 A 19810527; HK 81789 A 19891012; JP 8502481 A 19810604; NZ 19707081 A 19810512; PT 7310981 A 19810601; ZA 813235 A 19810514